ATS/IDSA/CDC release new guidelines on tuberculosis diagnosis

The updated guidelines now recommend testing for latent tuberculosis infection (LTBI) using an IGRA in individuals who are 5 years or older and who are likely to be infected with Mycobacterium tuberculosis (MTB), regardless of BCG vaccination.1 In individuals who are unlikely to be infected with MTB, but TB testing is required, IGRAs are now the recommended test method.1


About the T-SPOT®.TB test

The T-SPOT.TB test is a unique, single-visit blood test for tuberculosis (TB) screening, also known as an interferon gamma release assay (IGRA). The T-SPOT.TB test has demonstrated in a pivotal clinical study both sensitivity and specificity exceeding 95% and reliability in all at-risk groups.2 The T-SPOT.TB blood test does not cross react with the BCG vaccine and there is no association between T-SPOT.TB blood test results and immunocompromised status.2

Read more

Fill out the form below to get your own summarized copy of the latest guidelines